FISH MET 7q31 Amplification Test – Advanced Cancer Genetic Analysis
Comprehensive Introduction to MET Gene Amplification Testing
The FISH MET 7q31 Amplification Test represents a cutting-edge diagnostic approach in modern oncology, utilizing Fluorescence In Situ Hybridization (FISH) technology to detect amplification of the MET proto-oncogene located on chromosome 7q31. This sophisticated genetic analysis provides crucial information for cancer diagnosis, prognosis, and treatment selection, particularly in cases where MET gene abnormalities drive tumor growth and progression.
MET gene amplification is increasingly recognized as a significant biomarker in various cancers, making this test an essential tool for oncologists seeking to implement precision medicine strategies. By identifying patients with MET-driven cancers, healthcare providers can optimize treatment approaches and improve patient outcomes through targeted therapeutic interventions.
What the FISH MET 7q31 Amplification Test Detects
This specialized cytogenetic test specifically identifies:
- Amplification of the MET gene on chromosome 7q31
- Increased copy numbers of the MET proto-oncogene
- Genetic abnormalities associated with MET-driven tumor growth
- Biomarkers for targeted therapy eligibility
- Prognostic indicators for cancer progression
The test utilizes advanced FISH technology with specific probes targeting the MET gene region, providing highly accurate and reliable results for clinical decision-making.
Who Should Consider This Test
Clinical Indications and Patient Profiles
This test is particularly recommended for patients with:
- Non-small cell lung cancer (NSCLC) requiring targeted therapy assessment
- Gastric or gastroesophageal junction cancers
- Resistance to standard cancer treatments
- Metastatic cancers with unknown primary origins
- Family history of MET-related cancer syndromes
- Progressive disease despite conventional therapies
Symptoms and Clinical Scenarios
Patients experiencing unexplained weight loss, persistent cough, gastrointestinal symptoms, or those with confirmed cancer diagnoses may benefit from this genetic analysis to determine optimal treatment strategies.
Significant Benefits of MET Amplification Testing
Undergoing the FISH MET 7q31 Amplification Test offers numerous advantages:
- Personalized Treatment Planning: Identifies patients who may benefit from MET-targeted therapies
- Improved Prognostic Accuracy: Provides valuable information about disease progression and outcomes
- Therapeutic Guidance: Helps oncologists select the most effective treatment regimens
- Early Intervention Opportunities: Enables timely implementation of targeted therapies
- Comprehensive Cancer Profiling: Complements other genetic testing for complete molecular characterization
Understanding Your Test Results
Interpretation Guidelines
Your FISH MET 7q31 Amplification Test results will provide critical information about:
- Positive Amplification: Indicates increased MET gene copies, suggesting eligibility for targeted MET inhibitors
- Negative Result: No significant MET amplification detected, guiding alternative treatment considerations
- Borderline Findings: May require additional testing or clinical correlation
It’s essential to discuss your results with your oncologist, who will interpret them in the context of your specific clinical situation, overall health status, and treatment history. The results serve as a valuable component of your comprehensive cancer care plan.
Test Pricing and Availability
| Test Description | Regular Price | Discount Price |
|---|---|---|
| FISH MET 7q31 Amplification Test | $300 USD | $226 USD |
Turnaround Time and Sample Requirements
Reporting Time: 4 Working Days
Sample Submission: Daily by 4 PM
Sample Type: Formalin fixed paraffin embedded tissue block containing minimum 10% tumor tissue
Shipping: Room temperature
Required Documentation: Duly filled Chromosome & FISH analysis Requisition Form (Form 17)
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many other cities. Our extensive network ensures accessible genetic testing services for patients nationwide.
Take Action for Your Health Today
Don’t leave your cancer treatment decisions to chance. The FISH MET 7q31 Amplification Test provides the critical genetic information needed to make informed decisions about your cancer care. Our experienced cytogenetics team and state-of-the-art laboratory facilities ensure accurate, reliable results you can trust.
Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Our genetic specialists are available to answer your questions and guide you through the testing process.
Take the first step toward personalized cancer treatment with comprehensive genetic profiling. Early detection of MET amplification can significantly impact your treatment success and overall outcomes.
